Skip to content

Patient Reported Outcome Study on Long Term LoFric Users

Patient Reported Outcome Study on Long Term LoFric Users

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05359198
Enrollment
98
Registered
2022-05-03
Start date
2015-06-01
Completion date
2024-10-08
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Catheters

Brief summary

A prospective, observational cohort study evaluating Patient Reported Outcome in subjects with a long term experience from intermittent catheterization using the LoFric catheter. Prescription and use of LoFric catheters fall within current practice and is not dictated within this Non-Interventional Study.

Interventions

None listed

Sponsors

Wellspect HealthCare
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Provision of informed consent. 2. Female or male aged 18 years or older at time of signing informed consent. 3. Use of LoFric catheters for urethral intermittent catheterization for ≥ 6 years and currently using LoFric. 4. Able to read and write. 5. By investigator judged as able to comprehend and answer study questionnaires.

Exclusion criteria

1. Use of other catheter brand(s) than LoFric for \> 8 weeks in total during the past 12 months. 2. Simultaneous participation in any interfering clinical study as judged by the investigator. 3. Involvement in the planning and/or conduct of the NIS (applies to both Wellspect HealthCare staff and staff at the study site). 4. Previous enrolment in the present NIS.

Design outcomes

Primary

MeasureTime frameDescription
Document urological complications5 yearsNumber of UTIs last 12 months
Quality of Life Data5 yearsEQ-5D variables QoL data will be collected at each measuring point using the validated instrument EQ-5D-3L (EQ-5D). The EQ-5D, consisting of a questionnaire and a visual analogue scale (VAS), is a standardized health-related quality of life questionnaire developed by the EuroQoL Group in order to provide a simple, generic measure of health for clinical and economic appraisal. The VAS is a self-rated health status scale and records the subject's perception of his/her own current overall health and can be used to monitor changes over time. The questionnaire is a self-reported description of the subject's current health in 5 dimensions; mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The subject is asked to grade their own current level of function in each dimension on a three-graded scale (i.e. no problems, some problems or severe problems) and the combination of these creates a unique health state.
Patient perception of therapy5 yearsPRO variables Four questions regarding perception of subject's intermittent catheter therapy. Response on a 4 graded scale; Strongly agree, agree, disagree, strongly disagree. Changes will be followed during study period.
Patient perception of LoFric5 yearsPRO variables Eight questions regarding perception of subject's catheter. Response on a 4 graded scale; Strongly agree, agree, disagree, strongly disagree. Changes will be followed during study period.
Compliance/non-compliance to LoFric5 yearsPRO variables Type of catheter used collected during study period

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026